Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
20,788,527
-
Total 13F shares
-
175,227,518
-
Share change
-
-2,839,280
-
Total reported value
-
$3,781,950,206
-
Put/Call ratio
-
91%
-
Price per share
-
$21.58
-
Number of holders
-
265
-
Value change
-
-$41,488,916
-
Number of buys
-
130
-
Number of sells
-
148
Institutional Holders of Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) as of Q4 2019
As of 31 Dec 2019,
Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR) was held by
265 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
175,227,518 shares.
The largest 10 holders included
Invesco Ltd., PRIMECAP MANAGEMENT CO/CA/, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, FMR LLC, STATE STREET CORP, Camber Capital Management LP, Bellevue Group AG, and MAVERICK CAPITAL LTD.
This page lists
269
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.